METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24
Published March 1, 2017 · Recall initiated: February 10, 2017
Summary
FDA records drug Class II recall D-0480-2017, published March 1, 2017 and initiated February 10, 2017. Recalling firm: Hospira Inc., A Pfizer Company; Status: Terminated; Reported quantity: 578,784 bags; Lot: Lot: 54-054-JT, 6/1/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Sterility Assurance: customer report of leaking bag
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hospira Inc., A Pfizer Company
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot: 54-054-JT, 6/1/2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAArgatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by:July 26, 2017
- FDALevophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest,June 21, 2017
- FDAVancomycin Hydrochloride for Injection, USP, 10 grams, Pharmacy Bulk Package - Not For Direct Infusion, ForApril 12, 2017
- FDAPlum 360 Infusion Pump, Software Version 15.02. The infusion pump is capable of delivering fluids for aApril 5, 2017
- FDACycloSPORINE Capsules, USP, 100 mg, 30 count bottle, Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario,March 1, 2017
- FDATransderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged inMarch 1, 2017
Questions about this recall
Was METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24 recalled?
Yes. FDA published recall D-0480-2017 on March 1, 2017. Reported hazard: Lack of Sterility Assurance: customer report of leaking bag
What should I do if I have this product?
Voluntary: Firm initiated · Letter